GlassScriptPhysician profile
Tanner R Smith
NPI 1477288801
$1,504.23
in general payments reported to CMS, 2019-2025
10 companies · $390 in 2025
The $390 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $522 · 2024: $592 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,218 · Education: $286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,218.28 |
| Education | $285.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $483.77 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $467.87 | 2023-2025 | Dupixent |
| Janssen Biotech, INC. | $208.30 | 2023-2024 | Tremfya |
| Galderma Laboratories, L.P. | $94.12 | 2025 | Nemluvio |
| Lilly USA, LLC | $74.05 | 2023-2025 | Taltz, Olumiant, Ebglyss |
| Amgen INC. | $47.95 | 2023-2024 | Otezla, Enbrel |
| Genzyme Corporation | $44.78 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $37.78 | 2023-2024 | Jublia |
| Mayne Pharma Commercial LLC | $35.40 | 2023-2025 | |
| Organon LLC | $10.21 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tanner Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.